Pharmaceutical Dosage Forms Research Articles

Stability indicating RP-HPLC method development and validation for quantification of impurities in gonadotropin-releasing hormone (Elagolix): Robustness study by quality by design.

The purpose of this research was to establish and validate a reverse phase HPLC method for the determination of Elagolix impurities in pharmaceutical dosage form. Mobile phase A, consisting of 10mM sodium dihydrogen phosphate (pH6.0) and acetonitrile in a 95:5v/v ratio, and mobile phase B, containing 85:10:5v/v/v of acetonitrile, Milli-Q water, and methanol, were used to achieve the method's specificity in the analytical column Kromasil 100-C18 (250 mm × 4.6mm, 5μm). The gradient program includes (%B/Time [min]: 36/0, 36/10, 38/15, 85/55, 85/65, 36/67, and 36/75). The flow rate is 0.8mL/min. The overall run duration is 75.0min, the injection volume is 10.0μL, and the detection is at 210 nm in UV. The samples were subjected to hydrolysis, oxidation, and heat conditions in order to facilitate their forced degradation. The procedure was validated and determined with the standards of ICH guidelines. From the LOQ to a concentration level of 200%, the linearity of the technique was ascertained. An accuracy range of LOQ to 150% was established for the method, and the average recovery was acceptable. Design of experiments, part of the quality by design idea, was used to prove the method's reliability.

DEVELOPMENT OF NOVEL SINGLE HPLC METHOD FOR SIMULTANEOUS SEPARATION OF MULTIPLE IMPURITIES IN DEXAMETHASONE DRUG PRODUCT

Objective: A simple, reliable, and rapid HPLC method has been established for the detection of Dexamethasone (DEX) and its related impurities. The proposed method has been validated for specificity, linearity, system suitability, accuracy, precision, robustness, LOD, and LOQ as per International Council for Harmonisation (ICH) guidelines. All parameters were found to be within the accepted limits, affirming the method's reliability. Methods: Analysis was conducted using HPLC on X-Bridge C18 column (250 mm×4.6 mm id, 3.5 µm) with a mobile phase-A comprising buffer and acetonitrile (90:10, v/v), mobile phase-B comprising buffer and acetonitrile (25:75, v/v) and a flow rate of 0.8 ml/min by following gradient elution. The detection was performed with a UV detector set at 240 nm. The method has been employed to investigate DEX and DEX-related impurities. These studies were conducted in tablet formulations of DEX. Results: The Retention Time (tR) of DEX was about 41.589 min, and all parameters met acceptable limit values. The response exhibited linearity over a concentration range of 0.162 to 3.052 µg/ml (R2= 0.9999). The percentage of DEX recovered from the pharmaceutical tablet dosage form ranged from 96.3 % to 100.4 %. Sensitivity levels for the developed method were indicated by LOD and LOQ values of 0.081–0.162 µg/ml. The proposed method was validated according to ICH guideline. Conclusion: Hence, a simple, reliable, accurate, and precise HPLC method was developed, proving suitable for the separation of DEX and DEX-related impurities in commercial formulations.

A Comprehensive Review on Imperative Role of Ionic Liquids in Pharmaceutical Sciences.

Ionic liquids (ILs) are poorly-coordinated ionic salts that can exist as a liquid at room temperatures (or <100 °C). ILs are also referred to as "designer solvents" because so many of them have been created to solve particular synthetic issues. ILs are regarded as "green solvents" because they have several distinctive qualities, including better ionic conduction, recyclability, improved solvation ability, low volatility, and thermal stability. These have been at the forefront of the most innovative fields of science and technology during the past few years. ILs may be employed in new drug formulation development and drug design in the field of pharmacy for various functions such as improvement of solubility, targeted drug delivery, stabilizer, permeability enhancer, or improvement of bioavailability in the development of pharmaceutical or vaccine dosage formulations. Ionic liquids have become a key component in various areas such as synthetic and catalytic chemistry, extraction, analytics, biotechnology, etc., due to their superior abilities along with highly modifiable potential. This study concentrates on the usage of ILs in various pharmaceutical applications enlisting their numerous purposes from the delivery of drugs to pharmaceutical synthesis. To better comprehend cuttingedge technologies in IL-based drug delivery systems, highly focused mechanistic studies regarding the synthesis/preparation of ILs and their biocompatibility along with the ecotoxicological and biological effects need to be studied. The use of IL techniques can address key issues regarding pharmaceutical preparations such as lower solubility and bioavailability which plays a key role in the lack of effectiveness of significant commercially available drugs.

Analytical Method Developement and Validation of Beclomethasone, Clotrimazole, Ofloxacin, Lidocaine by RP-HPLC in Combination Dosage Form

A rapid and precise method (in accordance with ICH guidelines) is required for the quantitative simultaneous determination of drugs in a combined pharmaceutical dosage form. The pursuit of desired quality is a continual challenge for pharmaceutical industries, necessitating a meticulous approach known as validation. Sensitive and specific RP-HPLC method involving UV detection was carried for determination and quantification of various drug in combination dosage form. The aim is "Analytical Method developement and Validation of Beclomethasone, Clotrimazole, Ofloxacin, Lidocaine by RP- HPLC In Combination Dosage Form " as per ICH guidelines. The developed method was validated for various parameters as per ICH guidelines like system suitability, specificity, linearity, system precision, method precision, accuracy, ruggedness and robustness. The separation method was carried out by using a mobile phase A consisting of Potassium dihydrogen phosphate buffer (0.05M): Methanol 45:55 v/v) pH 3.5 ± 0.1 and Mobile phase B comprises Acetonitrile in the ratio of 50:50 v/v. The detection was carried out by using UV detector at 300nm. The column was Agilent C 18 (250X4.6mm) 5µ. The flow rate was selected as 1.5 ml/min. The retention time of Ofloxacin, Lidocaine, Beclomethasone, and Clotrimazole, was found to be 5.67, 9.44, 18.29, and 21.85 respectively.

Ultrasound-assisted extraction of itraconazole from pellets: an efficient approach for the recovery of active pharmaceutical compounds from solid dosage forms

IntroductionItraconazole is a widely used broad-spectrum antifungal drug on a global scale. However, its poor water solubility necessitates the development of advanced formulations for its effective use. Currently, itraconazole is available commercially in capsule form, with pellets containing the active drug. The extraction of itraconazole from these granules is often required when developing new formulations. Extracting active pharmaceutical ingredients (APIs) from pellets is crucial in ensuring precise and consistent dosing when producing pharmaceutical dosage forms. Surprisingly, no existing methods for extracting itraconazole from pellets have been reported thus far.ObjectiveTherefore, this study aimed to develop and evaluate an efficient method for extracting this API from pellets.MethodsTwo extraction methods were assessed: conventional Soxhlet extraction and ultrasound-assisted extraction.Results and DiscussionThe results demonstrated that ultrasound-assisted extraction significantly outperformed the conventional method, yielding higher amounts of itraconazole with a high purity level of 96.8%.

Pioneering simultaneous determination of breast cancer medications and metformin through sustainable micellar electrokinetic chromatographic method

The current study is the first report for the capillary electrophoretic simultaneous determination of five breast cancer medications, including febuxostat, quercetin, letrozole and doxorubicin in addition to metformin which is frequently co-administered with these drugs. The studied drugs are frequently purchased in different co-formulations used for breast cancer patients. A green micellar electrokinetic chromatographic (MEKC) method is proposed and optimized assisted by factorial design. The factors optimized include pH and concentration of buffer, surfactant concentration, as well as the applied voltage and injection time. The experimental results prove the optimum separation of the five drugs at pH 9.7 and buffer concentration of 10 mM with sodium dodecyl sulfate (SDS) concentration of 40 mM with +25 kV applied voltage. The developed method is validated considering linearity, precision, accuracy, and robustness adopting official guidelines. Good linearity is observed for all drugs, with correlation coefficients greater than 0.99. The range of percentage recoveries was from 98% to 102% with less than 2% relative standard deviation demonstrating the precision and accuracy of the established method. The study includes in-vitro assay of febuxostat, metformin, and doxorubicin in spiked human plasma. In addition, Accurate determination of the analytes under study in a variety of pharmaceutical dosage forms is accomplished by application of the proposed MEKC method. The greenness profile of the investigated method is confirmed using analytical eco-scale in addition to green analytical procedure index (GAPI) approaches.

Preparation, characterization, and in vitro cytogenotoxic evaluation of a novel dimenhydrinate-β-cyclodextrin inclusion complex.

Dimenhydrinate (DMH), used to alleviate motion sickness symptoms such as nausea, vomiting, dizziness, and vertigo, encounters limitations in oral pharmaceutical formulations due to its poor water solubility and bitter taste. Our research hypothesized that inclusion complexation with β-cyclodextrin (β-CD) might address these drawbacks while ensuring that the newly formed complexes exhibit no cytotoxic or genotoxic effects on peripheral blood mononuclear cells (PBMCs). Inclusion complexes were prepared using the kneading method and the solvent evaporation method. The phase solubility analysis, attenuated total reflectance-fourier transform infrared spectroscopy (ATR-FTIR), and differential scanning calorimetry (DSC) were conducted to evaluate the complexation efficacy and stability constant of the new binary systems. The results demonstrated that both methods provided complete and efficient complexation. Cytogenotoxic analysis, including the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay, alkaline comet assay, and cytokinesis-block micronucleus cytome (CBMN-cyt) assay, was conducted to assess the cytogenotoxic potential of DMH-β-CD inclusion complexes, a topic previously unexamined. No cytotoxic or genotoxic effects were observed within the concentration range of 36.36 to 109.09 ng/mL. Cell viability of treated PBMCs exceeded 85% for all tested concentrations. No significant increases in DNA strand breaks were observed at any dose, and tail intensity of all complexes remained lower or up to 2.2% higher than the negative control. Parameters indicating genotoxic effects, as well as cytotoxic and cytostatic potential in the CBMN-cyt assay, did not significantly differ from untreated controls. These results suggest that inclusion complexation with β-CD might be a safe and promising solution to overcome the limitations of poor solubility and unpleasant taste of DMH, potentially providing opportunities for new and improved oral pharmaceutical dosage forms.

First fluorescence method for monitoring the doping stimulant drug solriamfetol in plasma and urine: A pharmacokinetic study in volunteers’ urine with greenness, whiteness, and blueness assessments

A green, sustainable, simple, and highly sensitive spectrofluorimetric method was developed to determine solriamfetol hydrochloride for the first time in biological fluids and dosage form. To the best of our knowledge, no Fluorimetric methods have been reported for solriamfetol determination in plasma and urine. The method is based on measuring the intrinsic fluorescence of solriamfetol hydrochloride at 522 nm after excitation at 260 nm in ammonium acetate buffer solution at pH 4. All factors influencing the response have been carefully investigated. The method was linear over a concentration range of 10 to 1800 ng/mL (r = 0.9998). The limit of detection (LOD) and limit of quantification (LOQ) values were found to be 3.2 and 9.8 ng/mL, respectively, indicating the excellent sensitivity of the proposed method. The pharmaceutical dosage form, spiked human plasma, and urine samples were successfully analyzed using the described method with average recoveries of 99.79 ± 0.739, 99.27 ± 1.885, and 99.57 ± 1.701, respectively. Plasma samples were first subjected to protein precipitation using 10 % perchloric acid, while urine samples were analyzed directly without any pretreatment. Furthermore, the suggested method was applied effectively on real human volunteers’ urine to measure renal clearance, the cumulative amount of solriamfetol excreted unchanged in the urine, and the percent of the dose recovered. The eco-friendly nature and sustainability of this work were evaluated using trending greenness, whiteness, and blueness assessment metrics. The greenness assessment tools, namely the Analytical GREEnness metric tool (AGREE), Analytical Eco-scale, and complementary green analytical procedure index (complex GAPI) were selected to prove the eco-friendly nature of the method. Additionally, whiteness and blueness assessments were conducted using the Red-Green-Blue model (RGB model), and high Blue Applicability Grade Index (BAGI), respectively. The proposed method is a promising analytical tool for routine analysis in quality control labs, therapeutic drug monitoring, and pharmacokinetics studies.

Safety method, Spectrophotometric Determination of Sulfamethaxazole drug in bulk and Pharmaceutical Preparations

A simple, cheap, fast, accurate, Safety and sensitive spectrophotometric method for the determination of sulfamethaxazole (SFMx), in pure form and pharmaceutical dosage forms. has been described The Method is based on the diazotization of the drug by sodium nitrite in acidic medium at 5Cº followed by coupling with salbutamol sulphate (SBS) drug to form orange color the product was stabilized and measured at 452 nm Beer’s law is obeyed in the concentration range of 2.5-87.5 ?g ml-1 with molar absorptivity of 2.5x104 L mole-1 cm-1. All variables including the reagent concentration, reaction time, color stability period, and sulfamethaxazole /salbutamol ratio were studied in order to optimize the reaction conditions. No interferences were observed Results of analysis were validated statistically and by recovery studies. These methods are successfully employed for the determination of sulfamethaxazole in some pharmaceutical preparations.. The developed method is easy to use and accurate for routine studies relative to HPLC and other techniques.

Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route.

Migraine has a high prevalence worldwide and is one of the main disabling neurological diseases in individuals under the age of 50. In general, treatment includes the use of oral analgesics or non-steroidal anti-inflammatory drugs (NSAIDs) for mild attacks, and, for moderate or severe attacks, triptans or 5-HT1B/1D receptor agonists. However, the administration of antimigraine drugs in conventional oral pharmaceutical dosage forms is a challenge, since many molecules have difficulty crossing the blood-brain barrier (BBB) to reach the brain, which leads to bioavailability problems. Efforts have been made to find alternative delivery systems and/or routes for antimigraine drugs. In vivo studies have shown that it is possible to administer drugs directly into the brain via the intranasal (IN) or the nose-to-brain route, thus avoiding the need for the molecules to cross the BBB. In this field, the use of lipid nanoparticles, in particular solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), has shown promising results, since they have several advantages for drugs administered via the IN route, including increased absorption and reduced enzymatic degradation, improving bioavailability. Furthermore, SLN and NLC are capable of co-encapsulating drugs, promoting their simultaneous delivery to the site of therapeutic action, which can be a promising approach for the acute migraine treatment. This review highlights the potential of using SLN and NLC to improve the treatment of acute migraine via the nose-to-brain route. First sections describe the pathophysiology and the currently available pharmacological treatment for acute migraine, followed by an outline of the mechanisms underlying the nose-to-brain route. Afterwards, the main features of SLN and NLC and the most recent in vivo studies investigating the use of these nanoparticles for the treatment of acute migraine are presented.

One-Pot Synthesis of Sustainable Fluorescent Nanomaterials via Microwave Irradiation as a Probe for the Determination of Metformin in Pure and Pharmaceutical Dosage Forms: Greenness and Whiteness Metrics.

A rapid, green and sensitive technique for the determination of metformin determination was developed based on the direct fluorescence enhancement of carbon dots (CDs) induced by the cited drug. The water-soluble CDs were prepared via a one-pot synthesis from avocado peels using domestic microwave. The prepared CDs exhibited strong fluorescence at 405 nm after excitation at 320 nm with a quantum yield of 51%. The fluorescence of CDs was enhanced linearly by increasing the concentration of metformin within the range 0.5-25 μg/mL with limit of detection 0.087 μg/mL and limit of quantification 0.263 μg/mL. The designed probe was proved to be selective toward metformin in the presence of other drugs such as vildagliptin and alogliptin and also in the presence of excipients in the pharmaceutical dosage form. The suggested and reported methods were compared with the help of the whiteness and greenness tools, specifically the white analytical chemistry and analytical greenness metric tools, for assessing hazardous solvents and reagents used.

THE INDUSTRIAL IMPORTANCE OF TECHNOLOGY TRANSFER FOR ANALYTICAL METHOD DEVELOPMENT AND VALIDATION–APPLICATION TO VILAZODONE HYDROCHLORIDE DOSAGE FORM

Objective: The research aims to create a fast, economical, and efficient tech transfer method for analyzing bulk materials and pharmaceutical dosage forms. Methods: The analysis was performed using an Acquity UPLC BEH C18 analytical column (130 Å, 1.7 µm, 3 mm x 100 mm) with detection of the analyte at 238 nm. The mobile phase flow rate was optimized at 0.3 ml/min, and an injection volume of 0.5 µl** was used. The isocratic mobile phase consisted of a blend of buffer (0.1% OPA) and acetonitrile at a ratio of 40:60% v/v. Results: All validation parameters of the analytical method were acceptable. The analyte eluted at 3.08 min with satisfactory theoretical plates and a tailing factor. The recovery of the analyte was 99-100%, and the method's precision was 0.59 and 0.72% RSD. The technique showed no interference, indicating specificity. The linearity was demonstrated over the 20-60 µg/ml range, with a regression coefficient of 0.999. Conclusion: The developed method is cost-effective, specific with minimal interference, and time-saving. It also reduces solvent consumption for quality control analysis of vilazodone hydrochloride samples. The method demonstrates good linearity, robustness, and accuracy.

Modelling nematic liquid crystal in fractal dimensions

In this paper we present a fractal Berreman's model which account for azimuthal surface anchoring of nematic liquid crystals which play a leading role nowadays in biomedical field and pharmaceutical controlled release dosage forms. The model is based on the concept of "product-like fractal measure" in anisotropic media which permits to describe liquid crystals formation in terms of fractal dimensions. It was observed that fractal dimensions affect both the polar azimuthal angle and the Franck excess elastic energy density of the distortion. For fractal dimensions close to unity, our analysis reveals the emergence of fluctuations and large deformations in the dynamical variables of the theory which suggest the presence of non-linear elastic instabilities or emergence of defect structures in liquid crystals. These fluctuations fade away for fractal dimensions much less than unity. We have evaluated the elastic energy per unit of area which is found to depend on the square of the fractal dimension. This leads to a decrease of the saturation voltage which is necessary to reduce the elastic energy of liquid crystals films in order to minimize the elastic energy. This reduction may describe nematic liquid crystals free from deformations, singularities or weak anchoring surfaces.

Computationally Optimized Graphene-Based Electrochemical Sensor with Enhanced Signal Stability for the Determination of the Antimicrobial Agent 9-aminoacridine

A hydrophobic aryl diazonium salt has been synthesized from 3,5-bis(trifluoromethyl)aniline and utilized to covalently modify graphene nanoplatelets and carbon nanotubes. The modified nanomaterials were applied on a screen-printed electrode/ion sensing membrane interface resulting in reduced potential drift to 100 μV h−1 compared to control sensors. Characterization was achieved through X-ray photoelectron spectroscopy. The electrode’s response was optimized using response surface methodology and then utilized for determination of 9-Aminoacridine (9-AA) in pharmaceutical gel dosage form and spiked human plasma without prior extraction steps. 9-AA is a fluorescent dye with antimicrobial activity that eradicates a range of microorganisms that can cause oral sores or broken skin and it has been recently used as anticancer among other uses as fluorescent dye and pH indicator. Accurate determination of 9-AA could help in adjusting dosages for each application. The optimized sensor was validated per IUPAC guidelines and obtained a wide linearity range from 1.0 × 10–7 M to 1.0 × 10–2 M, correlation coefficient of 0.9997, improved Nernstian slope 59.72, long term stability, and lower limit of detection (9.0 × 10–8 M). Furthermore, Analytical Eco-scale and AGREE methods were utilized to evaluate the presented method’s greenness.

Application of stealth nanobeacon for traceability assurance in pharmaceutical tablets via surface-enhanced Raman scattering during the tablet coating process

Microtaggant technologies for on-dose authentication have garnered significant interest for use in the anti-counterfeit activities and traceability of pharmaceutical dosage forms. Previously, we proposed a stealth nanobeacon (NB) comprising self-assembled colloidal gold nanoparticles with reporter molecules that demonstrated characteristic surface-enhanced Raman scattering (SERS) activity. However, the integration of such microtaggants into standard production lines remains underexplored. In this study, we demonstrate the incorporation of NB into tablet coatings using a simple mixing method with conventional coating solutions. Rapid and discernible SERS responses from the NB-coated tablets were observed in response to laser excitation at 785 nm for 0.1s, implying that it is an advanced and efficient method for counterfeit detection. In addition, the SERS intensity of NB increased with coating time, suggesting that NB can be used as a tracer for the real-time monitoring of coating thickness. Furthermore, NB-coated tablets were indistinguishable from NB-free tablets, even during colorimetric analysis. These results suggest that the NB possesses stealth properties and can be easily incorporated into counterfeit detection products.

Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review

Background/Objectives: The pharmacy profession has undergone significant changes driven by advancements in patient care and healthcare systems. The FDA approval of Spritam® (levetiracetam), the first 3D-printed drug, has sparked increased interest in the use of Fused Deposition Modeling (FDM) 3D printing for pharmaceutical applications, particularly in the production of polypills. Methods: This review provides an overview of FDM 3D printing in the development of pharmaceutical dosage forms, focusing on its operation, printing parameters, materials, additives, advantages, and limitations. Key aspects, such as the ability to personalize medication and the challenges associated with the technique, including drug stability at high temperatures, are discussed. Results: Fourteen studies relevant to FDM 3D-printed polypills were analyzed from an initial pool of 60. The increasing number of publications highlights the growing global interest in this technology, with the UK contributing the highest number of studies. Conclusions: FDM 3D printing offers significant potential for personalized medicine by enabling precise control over dosage forms and tailoring treatments to individual patient needs. However, limitations such as high printing temperatures and the lack of standardized GMP guidelines for large-scale production must be addressed to fully realize its potential in pharmaceutical manufacturing.

Analytical Quality by Design (AQbD) Principles in Development and Validation of Stability‐Indicating RP‐HPLC Method for Simultaneous Estimation of Diltiazem HCl and Eugenol in Nanoethosomes

ABSTRACTThe study developed and validated a robust reverse‐phase high‐performance liquid chromatography (RP‐HPLC) method for a simultaneous estimation of Diltiazem HCl and Eugenol in nanoethosomes using analytical quality by design (AQbD) principles. The optimized method utilized a mobile phase of methanol and 0.1% Orthophosphoric acid (OPA) in a 50:50 % v/v ratio, with a flow rate of 1.0 mL/min and isocratic elution on a Phenomenex Luna C‐18 column (5 µm, 150 mm × 4.6 mm) at 30°C. This setup resulted in retention times of 6.838 min for Diltiazem HCl and 23.135 min for Eugenol. Validation followed International Council for Harmonization (ICH) Q2 (R1) guidelines, demonstrating excellent linearity with correlation coefficients of 0.9982 for Diltiazem HCl and 0.9991 for Eugenol across the 5–25 µg/mL range. The limits of detection (LOD) were 1.341 µg/mL for Diltiazem HCl and 0.960 µg/mL for Eugenol, with limits of quantification (LOQ) at 4.065 and 2.912 µg/mL, respectively. Stability testing under acidic, alkaline, oxidative, thermal, and photolytic conditions adhered to ICH Q1A (R2) and Q1B guidelines. This AQbD‐based method is effective for routine analysis of Diltiazem HCl and Eugenol in bulk and pharmaceutical dosage forms, fully complying with ICH standards.

Colorimetric approach based on iron oxide magnetic molecularly imprinted nanozyme for sensitive determination of antipyrine and benzocaine: Application to environmental water samples and pharmaceutical dosage form

Nanozymes provide the required enzymatic activity however, they lack the selectivity to target a certain drug during analysis. Herein, a novel polydopamine molecularly imprinted polymer (MIP) was fabricated onto Fe3O4 nanozymes surface for sensitive and selective determination of antipyrine (ANT) and benzocaine HCl (BEN). Synthesized Fe3O4 nanozyme with peroxidase like activity catalyzed the oxidation of ortho phenylenediamine by the aid of H2O2 to produce intense yellow color that can be measured via colorimetric assay. The MIPs were prepared and characterized using field-emission scanning electronic microscopy, Fourier-transform IR spectroscopy, surface area analysis, and X-ray diffraction spectrum. Two Fe3O4 @ MIP NPs nanozyme with peroxidase like activity of two drugs were prepared. Upon binding of the target drug with its respective MIP, an inhibition in the Fe3O4 enzymatic activity occurred and thus a decrease in the yellow color produced. This quantitative decrease in the color intensity represents the drug concentration. Factors affecting the enzymatic colorimetric reaction have been investigated and optimized. The formed MIPs increased the sensitivity of the proposed method with LOD 1.405, 0.658 ng mL−1, LOQ 4.259, 1.993 and recovery percentage of 100.07, 100.57 for ANT and BEN, respectively. The reusability of the Fe3O4 @ MIP NPs was assessed for six cycles without significant loss in enzymatic oxidase activity. Furthermore, the method was validated following ICH guidelines. Then, it was successfully applied for determination of the two drugs in spiked environmental water samples and pharmaceutical formulation.

A green approach: Simultaneous spectrophotometric detection of Co-administered levamisole and triclabendazole in Fasciola-infected sheep with environmental sustainability assessment

The goal of this work is to evaluate the greenness of six spectrophotometric approaches that have been presented for determining the binary combination of levamisole (LVA) and triclabendazole (TCZ). To evaluate the suggested approaches, the analytical community has taken an interest in using green analytical chemistry practices. Two tools, called "Analytical GREEness" (AGREE) and "Green Analytical Procedure Index" (GAPI), were utilized to assess the degree of greenness. The zero spectrum of TCZ and LVA is compared, and it is seen that their spectra overlap. This means that the six spectrophotometric methods can be used to find them: zero order (D0), first derivative (D1), second derivative (D2), the area under the curve (AUC), mean centering, and bivariate. Method I: The zero-order method (D0) is used to measure TCZ directly at 306 nm because LVA has no absorption. Method II: the first derivative method (D1) was used at wavelengths of 312 nm and 220 nm for TCZ and LVA respectively, and the linear range for TCZ and LVA was 2–18 μg/mL and 2–14 μg/mL, respectively. Method III: For the TCZ, the second derivative method (D2) was used at a wavelength of 312 nm and a linear range of 1–18 μg/mL. Method IV: The area under the curve (AUC) method was used with wavelengths of 202–207 nm and 218–226 nm, and concentrations of 2–14 μg/mL for LVA and 1–9 μg/mL for TCZ. Method V: we used a mean-centering method that involved dividing the mean-centered ratio spectrum by the spectrum of the 6 μg/mL TCZ and finding the mean-centered ratio values at 241 nm for LVA. Method VI: The bivariate method is based on measuring two components at two chosen wavelengths using the Kaiser Method. The wavelengths 215 and 225 nm gave the best value of K, so they could be used to find the concentrations of LVA and TCZ. It ranged from 2 to 16 μg/mL for TCZ and from 2 to 14 μg/mL for LVA. These methods were developed for analyzing binary mixtures in pharmaceutical dosage form and bulk powders with high recoveries. Following ICH guidelines, the developed techniques underwent validation. The results show that there were no significant differences when all methods were compared statistically to the described method for TCZ and LVA.

Advanced, Cutting-Edge RP-HPLC Methodology for the Comprehensive Quantitative Analysis of Assay of Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Co-Formulated Pharmaceutical Products.

In the current study, a simple and economic stability-indicating RP-HPLC method development and validation was carried out to estimate the bictegravir, emtricitabine and tenofovir from the pharmaceutical dosage form. 0.1M ammonium acetate in 0.5% v/v acetic acid solution and 1g of 1-octane sulfonic acid and adjustment of pH to 4.2 with dilute orthophosphoric acid done and methanol (40:60 v/v) was utilized as the mobile phase. The analysis was done using Inertsil ODS 3V (250 x 4.6 mm x 5 µm) column with column temperature kept at 30°C with an injection volume of 20 μL, flow rate of 1.0 ml/ minute and detection was carried out at 260 nm. The method was developed and it was validated according to ICH Q2 (R1) guidelines. The RT of bictegravir, emtricitabine and tenofovir were determined to be 12.23, 3.0 and 8.5 minutes, providing a reliable marker for its identification. The method was found linear from about 50 To 150% Of the target concentration of bictegravir emtricitabine and tenofovir with of 0.999. Significant degradation was observed in acidic, basic and peroxide stress conditions. Hence, it can be concluded that tablets are sensitive to acidic, basic and oxidation stress conditions. RSD for the peak area responses of emtricitabine, 0.03 and 0.03, respectively, indicating that the system is precise. The testing procedure was accurate from about 50 to 150%. Of the target concentration of emtricitabine, tenofovir alafenamide and bictegravir. The method was robust In relation to flow variation, column oven temperature variation, mobile phase variation and pH variation. In conclusion, our proposed RP-HPLC method provides a sensitive, accurate, and precise means of analyzing emtricitabine, tenofovir alafenamide and bictegravir from pharmaceutical dosage forms.